Key facts
- Notable investors include SOSV, IndieBio.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Ella (Pharmaceuticals and Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Ella (Pharmaceuticals and Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ella (Pharmaceuticals and Biotechnology)
Developer of a protein-based nanofilm technology designed to protect hair structure without causing damage. The company offers protein-derived nanofilm formulations, scalable application processes, and adaptable treatment methods, enabling cosmetic and biomedical researchers, haircare professionals, and healthcare developers to modify hair properties safely and support alternative therapeutic delivery approaches in biotechnology.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2021
- Ownership
- Privately Held (backing)
Ella (Pharmaceuticals and Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ella (Pharmaceuticals and Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ella (Pharmaceuticals and Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.